Cloud Banner

Medical Devices

Image

Global Respiratory Inhalers Market – Industry Trends and Forecast to 2030

  • Medical Devices
  • Upcoming Report
  • Sep 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Respiratory Inhalers Market, By Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Soft Mist Inhalers, Nebulizer), Patient (Adults, Pediatric), Technology (Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices), Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Others), End User (Hospitals, Clinics, Pharmacies, Respiratory Care Center, Other) – Industry Trends and Forecast to 2030.

Respiratory Inhalers Market

Respiratory Inhalers Market Analysis and Size

Respiratory inhalers are used to inhale medicines that are essential part of the treatment for chronic lung diseases. There are numerous products that deliver medicine directly to the airways such as dry powder inhalers, metered-dose inhalers (MDIs), nebulizers and soft mist inhalers. The rapidly increasing prevalence respiratory disorder across the world is amongst the significant factors fueling the growth and demand of global respiratory inhalers market. In addition, the increasing demand for treatment options for respiratory disorders and accessibility of well-developed technologies are also contributing to the growth.

Data Bridge Market Research analyses that the global respiratory inhalers market which was USD 32,516.5 million in 2022, is expected to reach USD 42,107.06 million by 2030, and is expected to undergo a CAGR of 5.87% during the forecast period 2023-2030. This indicates that the market value. “Soft Mist Inhalers” dominates the product segment of the global respiratory inhalers market owing to the rising awareness regarding pulmonary diseases as well as increasing healthcare spending are also lifting the growth of the market.  In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Respiratory Inhalers Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Soft Mist Inhalers, Nebulizer), Patient (Adults, Pediatric), Technology (Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices), Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Others), End User (Hospitals, Clinics, Pharmacies, Respiratory Care Center, Other)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa)

Market Players Covered

AstraZeneca (U.K.), Boehringer Ingelheim International GmbH (Germany), CHIESI Farmaceutici S.p.A. (Italy), GlaxoSmithKline plc (U.K.), Propeller Health (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Beximco Pharmaceuticals Ltd. (Bangladesh), 3M (U.S.), Cipla Inc. (India), Koninklijke Philips N.V. (Netherlands), Merck & Co., Inc. (U.S.), Omron Healthcare, Inc. (Japan), Cohero Health, Inc. (U.S.), PARI GmbH (Germany), Glenmark Pharmaceuticals Limited (India), Senzer Ltd (U.K.), Novartis AG (Switzerland), HELTMAN Medikal A.S. (Turkey), Mundipharma International (U.K.)

Market Opportunities

  • Increasing Global Pharmaceutical Production
  • Outsourcing of Quality Control Services

Market Definition

Respiratory inhalers are used to inhale medicines that are essential part of the treatment for chronic lung diseases. There are numerous products that deliver medicine directly to the airways such as dry powder inhalers, metered-dose inhalers (MDIs), nebulizers and soft mist inhalers.

Global Respiratory Inhalers Market Dynamics

Drivers

  • Increasing Prevalence of Respiratory Diseases

The rising incidence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis is a significant driver for the respiratory inhalers market. The growing global burden of these conditions drives the demand for effective inhalation therapies

  • . Technological Advancements in Inhaler Devices

Advances in inhaler technology have led to the development of more efficient and user-friendly inhalation devices. The introduction of digital inhalers, smart inhalers, and breath-actuated inhalers has improved medication delivery and patient adherence, driving market growth.

Opportunities

  • Expansion in Emerging Markets

Emerging economies offer significant growth opportunities for the respiratory inhalers market. Improving healthcare infrastructure, rising disposable incomes, and increasing awareness of respiratory diseases present a favorable market landscape for inhaler manufacturers.

  • Increasing Focus on Personalized Medicine

The shift towards personalized medicine creates opportunities for tailored respiratory inhaler solutions. Inhalers with customizable dosing, patient-specific treatment plans, and integrated digital technologies can improve patient outcomes and medication adherence.

Restraints/ Challenges

  • Stringent Regulatory Requirements:

Regulatory compliance poses challenges for inhaler manufacturers. Strict regulations regarding safety, efficacy, quality control, and device performance increase the time and cost required for product approvals, hindering market growth.

  • Pricing Pressure and Reimbursement Issues

Pricing pressures, cost containment efforts by healthcare systems, and reimbursement challenges can affect market growth. The availability of generic inhalers and the need for cost-effective treatment options may impact the profitability of inhaler manufacturers.

This global respiratory inhalers market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Respiratory Inhalers market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In September 2022, Beximco Pharmaceuticals launched ONRIVA TRIO BEXICAP which is a dry inhaler capsule. ONRIVA TRIO BEXICAPis indicated as maintainence therapy for asthma

Global Respiratory Inhalers Market Scope

The global respiratory inhalers market is segmented on the basis of product type, patient, technology, disease indication and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Product Type

  • Dry Powder Inhaler
  • Metered Dose Inhaler
  • Soft Mist Inhalers
  • Nebulizer

Patient

  • Adult
  • Pediatric

Technology

  • Manually Operated Inhaler Devices
  •  Digitally Operated Inhaler Devices

Disease Indication

End User

  • Hospitals
  • Clinics
  • Pharmacies
  • Respiratory Care Centre
  •  Other

Global Respiratory Inhalers Market Regional Analysis/Insights

The global respiratory inhalers market is analysed and market size insights and trends are provided by country, product type, patient, technology, disease indication and end user as referenced above.

The countries covered in the Respiratory Inhalers market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is likely to lead the global respiratory inhalers market. The regional market has been driven by the rising cases of chronic diseases such as cancer and increase in medical expenses in the region. However, the sudden boom in cancer diagnosis and the increasing rate of death is the main factor propelling the growth of the regional market.  

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to due to rise in the demand of health insurance policies in densely populated countries such as India and China.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

Global respiratory inhalers market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for respiratory inhalers market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global respiratory inhalers market. The data is available for historic period 2015-2020.

Competitive Landscape and Respiratory Inhalers Market Share Analysis

The global respiratory inhalers market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global respiratory inhalers market.

Some of the major players operating in the global respiratory inhalers market are:

  • AstraZeneca (U.K.)
  • Boehringer Ingelheim International GmbH (Germany)
  • CHIESI Farmaceutici S.p.A. (Italy)
  • GlaxoSmithKline plc (U.K.)
  • Propeller Health (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Beximco Pharmaceuticals Ltd. (Bangladesh)
  • 3M (U.S.)
  • Cipla Inc. (India)
  • Koninklijke Philips N.V. (Netherlands)
  • Merck & Co., Inc. (U.S.)
  • Omron Healthcare, Inc. (Japan)
  • Cohero Health, Inc. (U.S.)
  • PARI GmbH (Germany)
  • Glenmark Pharmaceuticals Limited (India)
  • Senzer Ltd (U.K.)
  • Novartis AG (Switzerland)
  • HELTMAN Medikal A.S. (Turkey)
  • Mundipharma International (U.K.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

Respiratory Inhalers Market will be worth USD 42,107.06 million by 2030.
Respiratory Inhalers Market growth rate is 5.87% during the forecast period.
Increasing Prevalence of Respiratory Diseases and Technological Advancements in Inhaler Devices are the growth drivers of the Respiratory Inhalers Market.
Product type, patient, technology, disease indication and end-user are the factors on which the Respiratory Inhalers Market research is based.
Beximco Pharmaceuticals launched ONRIVA TRIO BEXICAP which is a dry inhaler capsule. ONRIVA TRIO BEXICAPis indicated as maintainence therapy for asthma is the latest developments in the Respiratory Inhalers Market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials